Jane Brandman

Jane Brandman is an experienced executive in the pharmaceutical and biotechnology industries, currently serving as a Board Member at The Civilians and a Member at Chief while holding the position of Vice President, WW Hematology- Myeloma Strategy Lead at Bristol Myers Squibb since November 2020. Jane's prior roles include Vice President of Strategic Marketing Oncology at Bayer, and a series of leadership positions at Merck, where notable accomplishments involved developing the global strategy for the Keytruda lung cancer therapy, and driving successful launches and marketing initiatives in oncology and immunology across various organizations. Jane's educational background includes a Master of Science in Pharmaceutical Sciences from the University of Arizona and a Bachelor of Science in Pharmacy from the University of Alberta.